What's Happening
* Women may soon have access to a once-a-year treatment for osteoporosis. Reclast, by Novartis, is in the final stages of study and close to FDA consideration as osteoporosis treatment (CBSNews.com 9.19.06).
* If approved, the treatment would consist of one annual, 15-minute infusion to strengthen bones. Current treatments for osteoporosis include weekly pills (Fosamax and Actonel) and monthly pills (Boniva). Boniva can aso be given as an intravenous infusion every three months.
* Reclast's active ingredient is zoledronic acid, a drug used to treat cancer-related bone problems.
WHAT THIS MEANS TO BUSINESS
* Aging consumers are looking for convenient, easy and effective solutions that empower and fit into their active lifestyles.
Source: Iconoculture, 8/17/07
No comments:
Post a Comment